Massmutual Trust Co. FSB ADV Purchases 105 Shares of Synopsys, Inc. (NASDAQ:SNPS)

Massmutual Trust Co. FSB ADV grew its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 19.2% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 651 shares of the semiconductor company’s stock after purchasing an additional 105 shares during the quarter. Massmutual Trust Co. FSB ADV’s holdings in Synopsys were worth $387,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the business. Coldstream Capital Management Inc. increased its holdings in shares of Synopsys by 0.8% during the 4th quarter. Coldstream Capital Management Inc. now owns 2,195 shares of the semiconductor company’s stock worth $1,130,000 after purchasing an additional 18 shares during the period. Mission Wealth Management LP increased its stake in Synopsys by 2.5% during the fourth quarter. Mission Wealth Management LP now owns 780 shares of the semiconductor company’s stock valued at $401,000 after acquiring an additional 19 shares during the period. Hazlett Burt & Watson Inc. lifted its position in shares of Synopsys by 40.0% in the 1st quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $40,000 after acquiring an additional 20 shares during the period. Ignite Planners LLC grew its holdings in shares of Synopsys by 3.5% during the 1st quarter. Ignite Planners LLC now owns 596 shares of the semiconductor company’s stock worth $344,000 after purchasing an additional 20 shares in the last quarter. Finally, Monument Capital Management increased its position in shares of Synopsys by 1.1% during the first quarter. Monument Capital Management now owns 1,880 shares of the semiconductor company’s stock valued at $1,074,000 after purchasing an additional 20 shares during the period. 85.47% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on SNPS. JPMorgan Chase & Co. raised their target price on Synopsys from $650.00 to $655.00 and gave the stock an “overweight” rating in a research report on Thursday, May 23rd. Needham & Company LLC restated a “buy” rating and issued a $660.00 price target on shares of Synopsys in a research report on Thursday, May 23rd. Piper Sandler raised their price objective on shares of Synopsys from $672.00 to $687.00 and gave the stock an “overweight” rating in a report on Wednesday, July 10th. Robert W. Baird boosted their target price on Synopsys from $645.00 to $661.00 and gave the stock an “outperform” rating in a report on Tuesday, July 2nd. Finally, KeyCorp raised their price target on Synopsys from $675.00 to $690.00 and gave the company an “overweight” rating in a report on Thursday, June 27th. Eleven equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has an average rating of “Buy” and an average target price of $627.18.

Insider Buying and Selling at Synopsys

In other Synopsys news, CEO Sassine Ghazi sold 10,294 shares of the firm’s stock in a transaction dated Friday, May 24th. The stock was sold at an average price of $582.41, for a total value of $5,995,328.54. Following the completion of the sale, the chief executive officer now owns 62,568 shares of the company’s stock, valued at $36,440,228.88. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other Synopsys news, CEO Sassine Ghazi sold 10,294 shares of the stock in a transaction that occurred on Friday, May 24th. The stock was sold at an average price of $582.41, for a total transaction of $5,995,328.54. Following the completion of the transaction, the chief executive officer now owns 62,568 shares of the company’s stock, valued at $36,440,228.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider John F. Runkel, Jr. sold 936 shares of the firm’s stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $566.97, for a total transaction of $530,683.92. Following the sale, the insider now owns 20,000 shares of the company’s stock, valued at $11,339,400. The disclosure for this sale can be found here. Insiders have sold 81,363 shares of company stock valued at $49,361,263 in the last quarter. 0.66% of the stock is owned by insiders.

Synopsys Stock Down 3.5 %

Shares of Synopsys stock traded down $17.94 during trading on Monday, reaching $487.84. The company’s stock had a trading volume of 2,050,325 shares, compared to its average volume of 1,076,169. The company has a market cap of $74.75 billion, a price-to-earnings ratio of 52.69, a PEG ratio of 3.26 and a beta of 1.07. Synopsys, Inc. has a 52-week low of $418.51 and a 52-week high of $629.38. The firm’s 50-day moving average is $584.85 and its two-hundred day moving average is $567.42.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, May 22nd. The semiconductor company reported $3.00 EPS for the quarter, missing analysts’ consensus estimates of $3.03 by ($0.03). The business had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.50 billion. Synopsys had a net margin of 23.05% and a return on equity of 22.66%. The firm’s quarterly revenue was up 15.2% on a year-over-year basis. During the same period in the prior year, the company posted $1.76 earnings per share. On average, equities research analysts anticipate that Synopsys, Inc. will post 9.66 EPS for the current year.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.